PharmAla completes historic first shipment of MDMA from Canada to USA for use in a UCLA Clinical Trial ...

LEBANON, Tenn., March 3, 2025 /PRNewswire/ -- Cracker Barrel Old Country Store, Inc. ( "Cracker Barrel" or the "Company" ) CBRL today announced it has appointed industry-leading agencies to support its brand refresh, an important milestone in Cracker Barrel's journey to strengthen its connection ...

Wall Street is set for a higher open Monday, building off Friday's rally.

Palm Beach Gardens, Florida, March 03, 2025 ( GLOBE NEWSWIRE ) -- Datos Insights, a global advisory firm providing mission-critical insights on technology, regulations, strategy, and operations to the Financial Services industry, recognized Money Concepts as a winner of their 2024 Impact Award ...

BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 ( GLOBE NEWSWIRE ) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle ( LNP ) patent portfolio ( a subsidiary of Roivant Sciences, Ltd.

BASEL, Switzerland and VANCOUVER, British Columbia and WARMINSTER, Pa., March 03, 2025 ( GLOBE NEWSWIRE ) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle ( LNP ) patent portfolio ( a subsidiary of Roivant Sciences, Ltd. ( ...

Cegedim: Termination and implementation of a new liquidity contract Cegedim ( ISIN Code: FR0000053506 ) terminated the previous liquidity contract with Kepler Cheuvreux on February 28, 2025. As of that date, the following assets were booked to the liquidity account: • 10,259 Cegedim shares • ...

SOUTH SAN FRANCISCO, Calif., March 03, 2025 ( GLOBE NEWSWIRE ) -- Pliant Therapeutics, Inc. ( Nasdaq: PLRX ) today announced that following a prespecified data review and recommendation by the trial's independent Data Safety Monitoring Board ( DSMB ) , as well as a secondary review and ...

NEW YORK, March 03, 2025 ( GLOBE NEWSWIRE ) -- IN8bio, Inc. ( Nasdaq: INAB ) , a clinical-stage biopharmaceutical company developing innovative gamma-delta ( γδ ) T cell therapies, today unveiled INB-600, its potentially breakthrough next generation γδ T cell-based TCE platform.

• Flyte redefines on-demand air travel with a focus on regional connectivity, private charters, and curated getaways